Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
NCT ID: NCT00903240
Last Updated: 2011-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2009-05-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
NCT02969109
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561
Longitudinal Bladder Cancer Study for Tumour Recurrence
NCT05080998
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
NCT02700464
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for cystoscopy for transitional cell bladder cancer recurrence screening
* Urine donated prior to cystoscopy, Bladder biopsy, chemotherapy, intravesical therapy, radiation or TUR
* Must be willing to sign IRB approved informed consent
Exclusion Criteria
* Known diagnosis of any autoimmune disease or HIV, HCV or HBV
* History or current TB or any other active infection
* Subject has gross hematuria
* Receiving chemotherapy, intravesical therapy or radiation within 30 days of enrollment
* Any surgery except urologic within past 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Predictive Biosciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Predictive Biosciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Sheets, MD
Role: STUDY_DIRECTOR
Predictive Biosciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BCG Oncology
Phoenix, Arizona, United States
Urology Associates
Engelwood, Colorado, United States
Atlantic Urological Associates
Daytona Beach, Florida, United States
Winter Park Urology
Orlando, Florida, United States
Metropolitan Urology
Jeffersonville, Indiana, United States
Mayo Validation Support Services
Rochester, Minnesota, United States
Metro Urology
Woodbury, Minnesota, United States
Associates in Urology/Urology Group of NJ
741 Northfield Avenue, New Jersey, United States
Coastal Urology Associates
Brick, New Jersey, United States
Capital Regional Urological Surgeons
Albany, New York, United States
Community Care Physicians
Albany, New York, United States
University Urology Associates
New York, New York, United States
Hudson Valley Urology
Poughkeepsie, New York, United States
Associated Medical Professionals
Syracuse, New York, United States
The Urology Group
Cincinnati, Ohio, United States
Urological Associates of Lancaster
Lancaster, Pennsylvania, United States
Triangle Urologic Group
Pittsburgh, Pennsylvania, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Urology Clinics of North Texas
Dallas, Texas, United States
Urology San Antonio Research
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.